We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.63%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$713B
AUM Growth
+$53.3B
Cap. Flow
+$8.84B
Cap. Flow %
1.24%
Top 10 Hldgs %
20.41%
Holding
5,090
New
62
Increased
3,440
Reduced
905
Closed
188

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$784M
2
AAPL icon
Apple
AAPL
+$427M
3
DHR icon
Danaher
DHR
+$417M
4
PLD icon
Prologis
PLD
+$405M
5
AMZN icon
Amazon
AMZN
+$383M

Sector Composition

Rank Sector Weight
1 Technology 22.94%
2 Healthcare 15.43%
3 Financials 13.92%
4 Consumer Discretionary 9.78%
5 Industrials 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUSN
4476
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$79K ﹤0.01%
25,136
CRNT icon
4477
Ceragon Networks
CRNT
$201M
$78K ﹤0.01%
40,973
NDRA icon
4478
ENDRA Life Sciences
NDRA
$5.84M
$78K ﹤0.01%
11
+1
+10% +$8.38K
OGEN icon
4479
Oragenics
OGEN
$2.48M
$78K ﹤0.01%
415
-1
-0.2% -$353
TPST icon
4480
Tempest Therapeutics
TPST
$14.6M
$78K ﹤0.01%
5,178
-15
-0.3% -$316
VANI icon
4481
Vivani Medical
VANI
$122M
$78K ﹤0.01%
92,502
+7,063
+8% +$11.5K
AXLA
4482
DELISTED
Axcella Health Inc. Common Stock
AXLA
$78K ﹤0.01%
9,574
+1,134
+13% +$29.4K
HHR
4483
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$78K ﹤0.01%
28,935
CVU icon
4484
CPI Aerostructures
CVU
$68.5M
$77K ﹤0.01%
+24,180
New +$64.1K
DTST icon
4485
Data Storage Corp
DTST
$7.81M
$77K ﹤0.01%
52,762
-98
-0.2% -$186
BFRI icon
4486
Biofrontera
BFRI
$16.3M
$76K ﹤0.01%
4,155
+454
+12% +$9.27K
GRCL
4487
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
$76K ﹤0.01%
33,164
ACIU icon
4488
AC Immune
ACIU
$240M
$75K ﹤0.01%
37,118
CREX icon
4489
Creative Realities
CREX
$39.6M
$75K ﹤0.01%
43,177
-177
-0.4% -$324
CYN icon
4490
Cyngn
CYN
$17.7M
$75K ﹤0.01%
8
PCSA icon
4491
Processa Pharmaceuticals
PCSA
$8.61M
$75K ﹤0.01%
138
+8
+6% +$7.73K
NXTP
4492
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$75K ﹤0.01%
32,878
-78
-0.2% -$296
YCBD icon
4493
cbdMD
YCBD
$5.93M
$74K ﹤0.01%
910
-2
-0.2% -$201
CYTH
4494
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$74K ﹤0.01%
52,253
+3,937
+8% +$6.51K
ALLT icon
4495
Allot
ALLT
$383M
$73K ﹤0.01%
21,262
SWAG icon
4496
Stran & Co
SWAG
$36.5M
$73K ﹤0.01%
57,335
-151
-0.3% -$209
CMRA
4497
DELISTED
Comera Life Sciences Holdings, Inc. Common Stock
CMRA
$73K ﹤0.01%
60,008
+11,858
+25% +$17.3K
INDP icon
4498
Indaptus Therapeutics
INDP
$157M
$72K ﹤0.01%
1,804
-4
-0.2% -$202
MREO
4499
Mereo BioPharma
MREO
$47.3M
$72K ﹤0.01%
96,630
TAOX
4500
Tao Synergies Inc
TAOX
$25.2M
$72K ﹤0.01%
2,493
-6
-0.2% -$837

Similar funds

Geode Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, Geode Capital Management held 5,090 positions worth $713B, up 8.1% from $659B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q4 2022: portfolio turnover was 4.9%. Geode Capital Management opened 62 new positions and exited 188, leaving the 5,090-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Geode Capital Management's largest Q4 2022 buy was Ferguson: 1,854,192 shares worth $235M.
  • Geode Capital Management added most to Microsoft in Q4 2022, an estimated $784M increase.
  • Geode Capital Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $491M.
  • Geode Capital Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $587M.
  • Geode Capital Management's ten largest holdings make up 20% of its $713B portfolio in Q4 2022.
  • Geode Capital Management opened 62 new positions and closed 188 in Q4 2022.
  • Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $713B.

Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.